Profiles

Gustavo HMF Souza

KBI Biopharma, Inc.

Verified email at kbibiopharma.com

Cited by 2605

Biopharma mAb Proteomics Mass Spectrometry

Nimai Mandal

Principal Scientist & Head, CRURRS, Hazaribag (ICAR-National Rice Research Institute …

Verified email at icar.gov.in

Cited by 2603

Rice breeding drought blast MAB

Kun Lu

Emory university, HHMI

Cited by 2278

mAb protein biochemistry

Sha Sha

Scientist, Ultragenyx

Verified email at ultragenyx.com

Cited by 1225

Cell culture viral vector mAb bioinformatics mathematical modeling

Christopher Bianchetti

Pharmaceutical Product Development

Verified email at ppdi.com

Cited by 1186

Analytical Drug Development: AAV mAB LNP and cell based therapies

jai marathe

Verified email at bmc.org

Cited by 1173

HIV mAb contraceptive

Prof. dr hab. Tomasz Grabowski

Gdański Uniwersytet Medyczny

Verified email at gumed.edu.pl

Cited by 1135

Pharmacology monoclonals biosimilars mAb

Seyed Hossein Kiaie

Faculty of Pharmacy, Tabriz University of Medical Sciences

Verified email at tbzmed.ac.ir

Cited by 950

RNA therapeutics Lipid Nanoparticles mAb Formulation&Delivery Immunotherapy

Douglas F. Arbetter

Associate Director, Biotatistics, Moderna Therapeutics

Verified email at modernatx.com

Cited by 738

Clinical Trials Infectious Disease mAb Infection Vaccines

Hairui Zhang

Ultragenyx Pharmaceutical Inc.

Verified email at utexas.edu

Cited by 671

mAb mRNA-LNP CMC Formulation Development

1 - 10